Back
Eli Lilly and Vs. Regeneron Pharmaceuticals Sector Stock Comparison
Sell
48
LLY
Eli Lilly and
Last Price:
795.98
Seasonality Move:
4.05%
Sell
48
REGN
Regeneron Pharmaceuticals
Last Price:
772.89
Seasonality Move:
13.18%
Sell
48
Eli Lilly and (LLY)
is a Sell
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $799.58. The Score for LLY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- LLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $778.50. The Score for REGN is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $799.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing selling pressure, which indicates risk of future bearish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $778.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight buying pressure.
LLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.15 | Sell |
| Relative Strength Index (14 RSI): | 47.15 | Sell |
| Chaikin Money Flow: | -1859706 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (757.46 - 821.86) | Buy |
| Bollinger Bands (100): | (804.08 - 930.54) | Sell |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -27.34 | Sell |
| Relative Strength Index (14 RSI): | 41.65 | Sell |
| Chaikin Money Flow: | 122109 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (745.39 - 807.25) | Buy |
| Bollinger Bands (100): | (847.13 - 1152.45) | Sell |
LLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 811.73 | Sell |
| 20-day SMA: | 784.88 | Buy |
| 50-day SMA: | 840.62 | Sell |
| 200-day SMA: | 837.58 | Sell |
| 8-day EMA: | 805.93 | Sell |
| 20-day EMA: | 802.84 | Sell |
| 50-day EMA: | 828.59 | Sell |
| 200-day EMA: | 810.24 | Sell |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 766.1 | Buy |
| 20-day SMA: | 764.17 | Buy |
| 50-day SMA: | 873.11 | Sell |
| 200-day SMA: | 990.89 | Sell |
| 8-day EMA: | 770.42 | Buy |
| 20-day EMA: | 782.46 | Sell |
| 50-day EMA: | 860.09 | Sell |
| 200-day EMA: | 951.53 | Sell |
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.81 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.86 per share, and an increase next year of $9.29 per share.
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.49 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.54 per share, and an increase next year of $0.53 per share.
Eli Lilly and Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||